A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
for Type II Diabetes Mellitus
31 locations incl. Birmingham
Sponsor: Corxel Pharmaceuticals
Sex: All·Age: 18 - 75
Code: NCT07340320·Phase 2·Recruiting·Listed Jan 2026
M3 Wake Research - Dallas
Clinical research site in Dallas, Texas · M3 Wake Research Dallas, 411 N Washington Ave Suite 4100, Dallas, TX 75246 · (469) 297-3074 · Website
Part of M3 Wake Research
As of July 2026, 14 paid clinical trials are recruiting at M3 Wake Research - Dallas in Dallas, Texas. Active studies at this site cover conditions such as Advanced Breast Cancer, Advanced Hepatocellular Carcinoma and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at M3 Wake Research - Dallas (14)
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for Clostridioides Difficile Associated Disease
135 locations incl. Athens
Sponsor: Pfizer
Sex: All·Age: 65+·Accepts healthy volunteers
Code: NCT07282665·Phase 3·Recruiting·Listed Dec 2025
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for Metastatic Colorectal Cancer (CRC)
83 locations incl. Mobile
Sponsor: Summit Therapeutics
Sex: All·Age: 18+
Code: NCT07228832·Phase 3·Recruiting·Listed Nov 2025
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for High Risk Cardiovascular Disease
261 locations incl. Birmingham
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07181109·Phase 3·Recruiting·Listed Sep 2025
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
for Type 1 Diabetes Mellitus
33 locations incl. Tucson
Sponsor: COUR Pharmaceutical Development Company, Inc.
Sex: All·Age: 12 - 35
Code: NCT06783309·Phase 1, Phase 2·Recruiting·Listed Jan 2025
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
for Transthyretin Amyloidosis With Cardiomyopathy
39 locations incl. La Jolla
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18 - 85
Code: NCT07052903·Phase 3·Recruiting·Listed Jul 2025
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for Chronic Inflammatory Demyelinating Polyneuropathy
32 locations incl. Birmingham
Sponsor: Dianthus Therapeutics
Sex: All·Age: 18 - 75
Code: NCT06858579·Phase 3·Recruiting·Listed Mar 2025
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for Non-Small Cell Lung Cancer
89 locations incl. Chandler
Sponsor: Summit Therapeutics
Sex: All·Age: 18+
Code: NCT06767514·Phase 3·Recruiting·Listed Jan 2025
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for Generalized Myasthenia Gravis
32 locations incl. Birmingham
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT04202341·Recruiting·Listed Dec 2019
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
for Breast Cancer
40 locations incl. Tucson
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT06016738·Phase 3·Recruiting·Listed Aug 2023
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
for Locally Advanced / Metastatic Solid Tumors
14 locations incl. Birmingham
Sponsor: Crescent Biopharma, Inc.
Sex: All·Age: 18+
Code: NCT07335497·Phase 1, Phase 2·Recruiting·Listed Jan 2026
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
for Prosthetic-joint Infection
13 locations incl. Sarasota
Sponsor: Peptilogics
Sex: All·Age: 18 - 80
Code: NCT07214311·Phase 2, Phase 3·Recruiting·Listed Oct 2025
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
for Advanced Hepatocellular Carcinoma
15 locations incl. Phoenix
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06600321·Phase 1·Recruiting·Listed Sep 2024
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
for Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy
8 locations incl. Aurora
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18 - 85
Code: NCT07223203·Phase 3·Recruiting·Listed Oct 2025
More research sites in Dallas
- University of Texas Southwestern Medical Center (189 trials)
- UT Southwestern Medical Center (168 trials)
- UT Southwestern/Simmons Cancer Center-Dallas (73 trials)
- University of Texas Southwestern (63 trials)
- Baylor University Medical Center (43 trials)
- Medical City Dallas Hospital (26 trials)
- The University of Texas Southwestern Medical Center (25 trials)
- Parkland Memorial Hospital (24 trials)
- Mary Crowley Cancer Research (23 trials)
- UT Southwestern (23 trials)